Acrobot secures £2.6m windfall:
This article was originally published in Clinica
Computer-assisted surgery specialists Acrobot has secured £2.6m ($5.3m) in its first round of financing, allowing the company to take its technology to market and develop new products. The financing, which came from London Technology Fund, PUK Ventures and Imperial Innovations Group, will be used for the full commercialisation of the company's planner and navigation technologies, and continue the development of its active constraint technology for robotic applications. Acrobot (London, UK) had previously developed the navigation system in collaboration with UK orthopaedic device manufacturer the Corin Group, with the aim of combining robotic technology into the latter's Cormet metal on metal hip resurfacing implant.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.